The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.93BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
454.43MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-23.41%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Beta
1.97x
vs all stocks
Updated Oct 28, 2026
52-Week Change
-50.90%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
1.93BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
1.86BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
51.11x
vs Diagnostics & Research peers
Updated Oct 28, 2026
Price to Sales (TTM)
4.02x
vs Diagnostics & Research peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 4.25×.Updated Oct 28, 2026
Price to Book (MRQ)
7.48x
vs Diagnostics & Research peers
Updated Oct 28, 2026
Enterprise to Revenue
4.10x
vs Diagnostics & Research peers
Updated Oct 28, 2026
Enterprise to EBITDA
-55.25x
vs Diagnostics & Research peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 139.45×.Updated Oct 28, 2026
Gross Margin
68.37%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Profit Margin
-23.41%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Operating Margin
-15.21%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Return on Assets (TTM)
-7.89%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Return on Equity (TTM)
-40.80%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Revenue (TTM)
454.43MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
15.55USDUpdated Oct 28, 2026
Quarterly Revenue Growth
11.40%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Gross Profit (TTM)
315.30MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
13.35MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-106.36MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Quarterly Earnings Growth (YoY)
11.44%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-48.71MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
-47.50MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Diagnostics & Research peers
Updated Oct 28, 2026
Revenue
427.54MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
129.37MUSDFY2025 · Dec 31, 2025
Gross Profit
298.17MUSDFY2025 · Dec 31, 2025
Operating Income
-13.08MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-21.14MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-116.00KUSDFY2025 · Dec 31, 2025
Net Income
-21.02MUSDFY2025 · Dec 31, 2025
EBIT
-13.08MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
13.35MUSDFY2025 · Dec 31, 2025
Research & Development
72.03MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
239.22MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.7300USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.7300USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
28.64MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
28.64MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-21.02MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
21.04MUSDFY2025 · Dec 31, 2025
Free Cash Flow
2.03MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
105.99MUSDFY2025 · Dec 31, 2025
Income Tax Paid
1.27MUSDFY2025 · Dec 31, 2025
Interest Paid
6.41MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-21.02MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
25.22MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
32.16MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
12.38MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-36.23MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
8.53MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-19.02MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025
Net Acquisitions
-32.86MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-55.68MUSDFY2025 · Dec 31, 2025
Sale of Investments
46.03MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-61.52MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.66MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
43.04MUSDFY2025 · Dec 31, 2025
Shares Outstanding
29.80MSharesUpdated Oct 28, 2026
Float Shares
20.44MSharesUpdated Oct 28, 2026
Shares Short
5.63MSharesUpdated Oct 28, 2026
Short Ratio
7.71days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
36.11%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 18.88%.Updated Oct 28, 2026
% Held by Insiders
7.71%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
108.64%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
132.55MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
4.45USDUpdated Oct 28, 2026
Total Debt (MRQ)
167.40MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
0.6855x
vs Diagnostics & Research peers
Updated Oct 28, 2026
Current Ratio (MRQ)
3.30x
vs Diagnostics & Research peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
8.19USDUpdated Oct 28, 2026
Total Assets
523.71MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
268.29MUSDFY2025 · Dec 31, 2025
Total Liabilities
215.53MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
255.42MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
106.62MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
108.91MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
105.00MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
66.28MUSDFY2025 · Dec 31, 2025
Accounts Receivable
74.37MUSDFY2025 · Dec 31, 2025
Inventory
13.95MUSDFY2025 · Dec 31, 2025
Accounts Payable
2.46MUSDFY2025 · Dec 31, 2025
Short-term Debt
8.95MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
11.27MUSDFY2025 · Dec 31, 2025
Long-term Debt
104.22MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.64MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.37BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
308.18MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
32.21USDUpdated Oct 28, 2026
52-Week High
170.87USDUpdated Oct 28, 2026
52-Week Change
-50.90%
vs all stocks
Updated Oct 28, 2026
Beta
1.97x
vs all stocks
Updated Oct 28, 2026
50-Day MA
80.01USDUpdated Oct 28, 2026
200-Day MA
72.93USDUpdated Oct 28, 2026
Avg 10-Day Volume
909.56KSharesUpdated Oct 28, 2026
Avg 30-Day Volume
865.15KSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-3.63USDUpdated Oct 28, 2026
Other Income / Expense
-5.52MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -40.8%, lower than 95% of its Diagnostics & Research peers (median 2.1%)Significant
Return on equity: -0.41Industry median: 0.02Industry P5: -0.24Peers compared: 27.00
Structural Tensions
High gross margins eroded by operating costsNotable